Daxor Long Term Debt 2012-2011 | DXR

Daxor long term debt from 2012 to 2011. Long term debt can be defined as the sum of all long term debt fields.
Unlock Macrotrends Premium
40 years of data
Faster, ad-free pages
Unlimited data exports
Full-width charts
Daxor Annual Long Term Debt
(Millions of US $)
Daxor Quarterly Long Term Debt
(Millions of US $)
Sector Industry Market Cap Revenue
Medical Medical - Outpatient & Home Care $0.065B $0.000B
Daxor Corporation is a medical device manufacturing corporation with additional biotech services.
Stock Name Country Market Cap PE Ratio
Fresenius SE (FSNUY) Germany $29.581B 13.26
Quest Diagnostics (DGX) United States $27.271B 23.22
DaVita (DVA) United States $12.179B 14.91
Encompass Health (EHC) United States $12.036B 20.89
Elanco Animal Health (ELAN) United States $11.491B 21.70
Chemed (CHE) United States $6.620B 23.60
RadNet (RDNT) United States $6.069B 175.27
LifeStance Health (LFST) United States $4.991B 100.46
Option Care Health (OPCH) United States $3.523B 14.89
Aveanna Healthcare Holdings (AVAH) United States $3.123B 21.68
Addus HomeCare (ADUS) United States $2.164B 19.57
Astrana Health (ASTH) United States $2.138B 22.69
Pennant (PNTG) United States $1.396B 36.34
U.S Physical Therapy (USPH) United States $1.220B 32.19
MEDIROM Healthcare Technologies (MRM) Japan $0.024B 0.00
Psychemedics (PMD) United States $0.000B 0.00